CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 103 filers reported holding CONSTELLATION PHARMCETICLS I in Q4 2019. The put-call ratio across all filers is 0.31 and the average weighting 2.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $53,762,000 | +4.7% | 1,590,606 | -27.5% | 0.00% | 0.0% |
| Q1 2021 | $51,327,000 | +7.5% | 2,194,414 | +32.4% | 0.00% | 0.0% |
| Q4 2020 | $47,730,000 | +8.7% | 1,657,307 | -23.5% | 0.00% | 0.0% |
| Q3 2020 | $43,900,000 | +5.9% | 2,166,813 | +57.1% | 0.00% | 0.0% |
| Q2 2020 | $41,459,000 | +275.1% | 1,379,671 | +292.3% | 0.00% | +200.0% |
| Q1 2020 | $11,052,000 | -14.5% | 351,644 | +28.2% | 0.00% | 0.0% |
| Q4 2019 | $12,920,000 | +690.2% | 274,244 | +8.4% | 0.00% | – |
| Q3 2019 | $1,635,000 | -47.5% | 253,030 | -0.2% | 0.00% | – |
| Q2 2019 | $3,112,000 | +29.0% | 253,439 | +42.3% | 0.00% | – |
| Q1 2019 | $2,413,000 | +3448.5% | 178,050 | +953.9% | 0.00% | – |
| Q4 2018 | $68,000 | – | 16,894 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP, LLC | 3,034,083 | $41,112,000 | 40.71% |
| Svennilson Peter | 4,677,939 | $63,386,000 | 33.76% |
| VHCP Management II, LLC | 726,677 | $9,846,000 | 2.88% |
| Casdin Capital, LLC | 1,556,999 | $21,097,000 | 2.32% |
| Cormorant Asset Management, LP | 1,271,687 | $17,231,000 | 1.16% |
| VHCP Management III, LLC | 66,667 | $903,000 | 0.53% |
| Hillhouse Capital Management | 317,921 | $4,308,000 | 0.18% |
| Orbimed Advisors | 835,842 | $11,326,000 | 0.18% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 66,186 | $897,000 | 0.13% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 253,400 | $3,434,000 | 0.13% |